Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2012/12/003267
CTRI/2012/12/003267
Recruiting
Phase 4

Randomized trial of systemic steroids (prednisolone) and propranolol in the treatment of Infantile Hemangiomas

Indian Council of Medical Research0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Indian Council of Medical Research
Enrollment
40
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Age up to 1 year
  • •2\.Active Infantile hemangioma having functional or cosmetic concern.(Nasal tip, eye lids, ears, face, genitalia)
  • •3\.Infantile hemangiomas with ulcerations/hemorrhage/necrosis
  • •4\.Infantile hemangiomas with life threatening locations (mouth, tongue, and upper airways
  • •5\.Infantile hemangiomas with \> 5 lesions

Exclusion Criteria

  • •1\.Age more than 1 year
  • •2\.Congenital Hemangiomas (Fully developed hemangiomas at birth) \[Rapidly involuting congenital hemangiomas (RICH) and Non involuting congenital hemangiomas (NICH)
  • •3\.Children with bleeding diathesis
  • •4\.Systemic involvement.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Steroid infusion using a spray tube after ESD for esophageal canceresophageal cancer
JPRN-jRCT1061220099Goto Atsushi100
Active, not recruiting
Not Applicable
Randomized controlled trial of prednisolone in the treatment of osteaoarthritis of the hand - BELIOAOsteoarthritis of the hands
EUCTR2005-005442-39-ATDivision of Rheumatology250
Completed
Not Applicable
The effect of Prednisolone in reducing of recurrent abortioIdiopathic Recurrent Abortion.Miscarriage
IRCT2013110915342N1Avicenna Research Institute100
Recruiting
Phase 2
A clinical trial of steroid therapy for patients with FCMD caused by a homozygous(hetrozygous) 3kb insertion in FKTN gene.Fukuyama-type congenital muscular dystrophy
JPRN-jRCT2031230211Ishigaki Keiko20
Recruiting
Phase 2
A clinical trial of steroid therapy for patients with FCMD caused by a homozygous 3kb insertion in FKTN gene.Fukuyama-type congenital muscular dystrophy
JPRN-jRCT2031230210Ishigaki Keiko15